Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.

Annual Revenue ($)

Veracyte revenue was $117.48 m in FY, 2020

Quarterly Revenue ($)

FY, 2017FY, 2018FY, 2019FY, 2020
Revenue$71.95 m$92.01 m$120.37 m$117.48 m
Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021
Revenue$20.04 m$22.75 m$23.47 m$29.53 m$30.14 m$30.97 m$31.12 m$20.7 m$31.12 m$36.7 m$50.79 m

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Veracyte revenue breakdown by business segment: 6.7% from Biopharmaceutical Revenue, 89.2% from Testing Revenue and 4.1% from Other

FY, 2019FY, 2018
Biopharmaceutical Revenue$8.09 m$950 k
Testing Revenue$107.36 m$91.06 m
Collaboration Revenue$4 m
Product Revenue$923 k

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu